Clinical Trials Logo

Filter by:
NCT ID: NCT00537329 Completed - Candidemia Clinical Trials

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether or not the Investigational Study Drug anidulafungin is safe and effective in the treatment of a fungal infection, candidemia, in Asian subjects.

NCT ID: NCT00534391 Recruiting - Hordeolum Clinical Trials

Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage

Start date: September 2007
Phase: Phase 3
Study type: Interventional

To compare the effectiveness of combined antibiotic ophthalmic solution (neomycin sulfate, polymyxin B sulfate and gramicidin) with placebo (artificial tear) in the treatment of hordeolum after incision and curettage

NCT ID: NCT00531479 Completed - Aspergillosis Clinical Trials

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Start date: July 2008
Phase: Phase 3
Study type: Interventional

This study compares the effectiveness and safety of the combination of anidulafungin and voriconazole compared to that of voriconazole alone (which is generally considered the standard of care) for the treatment of Invasive Aspergillosis.

NCT ID: NCT00529451 Completed - Hypertension Clinical Trials

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Start date: September 2007
Phase: Phase 3
Study type: Interventional

This study is designed to investigate the efficacy, safety and tolerability of aliskiren 300 mg, 150 mg and 75 mg when compared to ramipril 5 mg in patients with essential hypertension.

NCT ID: NCT00528567 Completed - Breast Cancer Clinical Trials

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The main objective of the trial is to compare Invasive Disease-Free Survival (IDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant chemotherapy with 1 year of bevacizumab. The secondary objectives of this trial are to: - compare Overall Survival (OS), Breast Cancer-Free Interval (BCFI), Disease- Free Survival (DFS) and Distant Disease-Free Survival (DDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant chemotherapy in combination with 1 year of bevacizumab - evaluate the safety and tolerability of bevacizumab An exploratory sub-study (not reported here) was to identify biomarkers (from tumour or serum) predictive of toxicity and for the level of benefit from the addition of bevacizumab to standard adjuvant systemic treatment.

NCT ID: NCT00528151 Completed - Clinical trials for Optic Atrophy, Hereditary, Leber

A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)

Start date: May 2005
Phase: Phase 3
Study type: Interventional

Background Leber's Hereditary Optic Neuropathy (LHON) is a maternally inherited ocular disorder associated with a mutation in mtDNA . The common manifestation is visual loss which caused by the respiratory chain enzymes complex dysfunction resulting in increased oxidative stress enzymes production. Purpose To determine whether curcumin which is an antioxidant agent is beneficial to the patients with 11778 LHON mutation. Material and Method Seventy patients with 11778 LHON mutation were randomly treated with oral curcumin (500 mg/day) and placebo for 1 year. The visual acuity, computerized visual field, electrophysiologic parameters and oxidative stress enzymes in plasma were compared before and after treatment at 3, 6, and 12 months interval.

NCT ID: NCT00526864 Completed - Herpes Zoster Clinical Trials

Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand

Start date: May 2007
Phase: N/A
Study type: Observational

Total 7 institutions will be recruited i.e. Clinical Infectious Disease Research Unit Department of Clinical Tropical Medicine, Faculty of Tropical Medicine Mahidol University,Bamrasnaradura Infectious Disease Institute ,Pramonkutklao Hospital,Rajavithi Hospital,NationalCancerInstitute,Institute of Dermatology,Raj Pracha Samasai Institute OBJECTIVES - Measure the burden of illness due to herpes zoster (Zoster) and post-herpetic neuralgia (PHN) (severity and duration); - Assess the quality of life (QoL) and quality adjusted life years (QALY) lost due to Zoster and PHN; - Describe health care resource utilization associated with Zoster and PHN; - Describe the direct and indirect costs per case of Zoster and PHN

NCT ID: NCT00524368 Completed - Clinical trials for Human Immunodeficiency Virus - Type 1

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

ODIN
Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to test if being treated with darunavir/ritonavir (DRV/rtv) 800/100 mg daily is as effective as being treated with DRV/rtv 600/100 mg twice daily, in early antiretroviral (ARV)-experienced patients when given along with selected optimized background regimen (OBR).

NCT ID: NCT00520338 Completed - Postoperative Pain Clinical Trials

Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial

Start date: August 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether celecoxib is effective in the treatment postoperative pain after thyroidectomy. The research hypothesis: There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib or placebo.

NCT ID: NCT00520117 Completed - Papanicolaou Smear Clinical Trials

Assessing the Psychosocial Burden in Women With an Abnormal Pap Results After Screening Interventions

Start date: June 2007
Phase:
Study type: Observational

The primary purpose of this study is to assess the psychosocial burden in women who have experienced an abnormal pap results after screening interventions.